| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.27 | 4e-10 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |